The DOI matches its Crossref record; 137 of the 138 references it cites were found in a registry or an index.
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities
Abstract
The first disulfide linkage-employing drug conjugate that exploits the reversible nature of this unique covalent bond was recently approved for human use. Increasing numbers of drug formulations that incorporate disulfide bonds have been reported, particularly in the next generation macromolecular pharmaceuticals. These are designed to exploit differences in the reduction potential at different locations within and upon cells. The recent characterization of a novel redox enzyme in endosomes and lysosomes adds more excitement to this approach. This review focuses on understanding where and how the disulfide bond in the bioconjugate is reduced upon contact with biological milieu, which affects delivery design and the interpretation of the delivery strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This makes glutathione an excellent target for drug delivery in cancer therapy [211,212,213,214,215].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [211]
Citations
Cites
Meister, A., & Anderson, M. E. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003431 · Cited by 5,680
Physiological functions of thioredoxin and thioredoxin reductase
Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,525
Oxidized Redox State of Glutathione in the Endoplasmic Reticulum
Hwang, C., Sinskey, A. J., & Lodish, H. F. (1992) · Science · doi:10.1126/science.1523409 · Cited by 1,968
Thioredoxin and Glutaredoxin Systems
Holmgren, A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71625-6 · Cited by 1,796
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Self-citationCarlsson, J., Drevin, H., & Axén, R. (1978) · Biochemical Journal · doi:10.1042/bj1730723 · Cited by 1,215
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
Haensler, J., & Szoka, F. C. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a012 · Cited by 1,207
[21] Thioredoxin and thioredoxin reductase
Holmgren, A., & Bjornstedt, M. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)52023-6 · Cited by 941
Meister, A. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90076-x · Cited by 907
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01447-4 · Cited by 803
Research works printed but not linked: 3
- Gilbert, 1995, Thiol/disulfide exchange equilibria and disulfide bond stability, Exp. Neurol., 132, 54
- Niculescu-Duvaz, 2000, Technology evaluation: gemtuzumab ozogamicin, Curr. Opin. Mol. Ther., 2, 691
- Nakanishi, 2000, Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway, Eur. J. Immunol., 30, 1740, 10.1002/1521-4141(200006)30:6<1740::aid-immu1740>3.0.co;2-u · doi:10.1002/1521-4141(200006)30:6<1740::aid-immu1740>3.0.co;2-u
Cited by
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
“The reducing nature of the cytosol has been used extensively in protein–conjugate chemistry to trigger release of the payload on cellular internalization with cargos ranging from oligonucleotides to toxins and chemotherapeutic”
BackgroundKamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
“Lastly, intracellular glutathione (GSH) levels in tumor cells are 100–1000 fold higher than the extracellular levels [11].”
BackgroundInfluentialSmart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Sahandi Zangabad, P., Rahighi, R., Moosavi Basri, S. M., Mirshekari, H., Amiri, M., Shafaei Pishabad, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,519
Metadata
- Authors
- Saito, G., Swanson, J. A., & Lee, K.-D.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Lee, Kyung-Dall
- ORCID
- Swanson, Joel A
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 55
- Issue
- 2
- Pages
- 199-215
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2055991021
- Cited by
- 1,407
- References
- 138
- Citations by year
- 2026: 33 · 2025: 34 · 2024: 38 · 2023: 44 · 2022: 39 · 2021: 56 · 2020: 70 · 2019: 71 · 2018: 76 · 2017: 87 · 2016: 106 · 2015: 117 · 2014: 102 · 2013: 127 · 2012: 99
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI035950)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- disulfide bonds, drug conjugates, bioconjugates, oxidative enzymes, endosomes, lysosomes, drug delivery methods, redox potential
- MeSH terms
- Animals, Antibodies, Cell Membrane, Disulfides, Pharmaceutical Preparations, Endocytosis, Enzymes, Humans, Oxidation-Reduction, Sulfhydryl Compounds, Drug Design, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. https://app.cochat.ai/papers/10.1016/s0169-409x(02)00179-5
- The paper
- Saito, G., Swanson, J. A., & Lee, K.-D. (2003). Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Advanced Drug Delivery Reviews. https://doi.org/10.1016/s0169-409x(02)00179-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.